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VOICES (Voice Outcomes and Inquiry of
Cough and Essentials in Swallowing) Lab

By: Emma Bozarth, Sarah Popp, Lyndsay Hutton, Serena Haller
& Laurie Slovarp, Ph.D., CCC-SLP, BCS-S

Introduction
About 10-20% of patients who suffer from
chronic cough do not respond to medical
4
treatment . They are said to have refractory
chronic cough (RCC). Research has shown the
underlying cause of RCC in many patients is
hypersensitivity in the airway leading this subset
of cough to be called cough hypersensitivity
3
syndrome (CHS) . Many patients with CHS are
successfully treated with behavioral cough
suppression therapy (BCST). BCST primarily
consists of suppressing the cough. Within 2-4
weeks the sensitivity returns to normal. Experts
theorize the change is due to the use-it or lose-it
principle of neuroplasticity1. Although BCST is
an effective treatment in up to 88% of patients
with RCC4, some patients have such a strong
urge-to -cough (UTC) they cannot suppress it at
all. We hypothesize these patients would benefit
from BCST is they could be presented with
cough stimulant strong enough to elicit UTC but
weak enough for cough suppression.

Research Question
Is it possible to decrease cough sensitivity by
exposing patients to increasing doses of
aerosolized capsaicin (a known cough stimulant)
combined with active cough suppression?

relaxed/open throat breathing
sip water
hard swallow
breath hold

Participants
3 healthy controls (no respiratory issues) recruited
from CSD department
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Methods
Baseline Testing
• Determine cough sensitivity on healthy control: by measuring
the amount of inhaled capsaicin that causes two coughs (C2)
and five coughs (C5)2
• Teach behavioral cough suppression techniques (BCST) ask
participants to practice relaxed throat breathing twice a day

Cough Suppression Strategies
•
•
•
•

All 3 subjects were able to successfully
suppress their cough at the highest capsaicin dose
(1000 uM) after treatment sessions. Post-treatment
testing 1 week following treatment revealed a
significant decrease in cough sensitivity for all 3
participants. In general C2 did not change as much
as C5.
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Purpose
The purpose of this study was to determine
feasibility of decreasing cough sensitivity
through use of cough suppression strategies
following inhalation of capsaicin in gradually
increasing doses, across repeated treatment
sessions.

Results

Treatment Sessions
• 3x/week for two weeks
• Practice BCST following inhalation of capsaicin at increasing

doses

Post-treatment Testing
•

Retest cough sensitivity one week and three weeks posttreatment
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Future Directions
This study shows feasibility of testing
programmatic desensitization coupled with cough
suppression in a larger sample with a placebo
group. Similar results in a larger sample with
placebo will provide a rationale for testing on
patients with CHS. Ultimately, if this treatment
works, it could significantly change how CHS is
treated in the future.
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